Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Genentech Sees Bicycle As Route To Novel Targeted Cancer Immunotherapies

DealWatch_1200x675

Related Content

Keeping Track: US FDA Approves Novel Tetracyclines Nuzyra And Seysara; Hemlibra Indication Expands

Oct 07 2018

BMS and Five Prime push the immune-oncology deal bandwagon along

Mar 17 2014

Bicycle Partners With Biogen Spinout Against Rare Blood Disorders

Sep 06 2017

Norgine Builds Specialty Business In Europe From Canada's Merus Labs

Jul 20 2017

Codagenix-Serum Join Fray To Develop SARS-CoV-2 Vaccine

Feb 14 2020

GSK Partnership With Immatics Seeks TCR Therapeutics For Solid Tumors

Feb 20 2020

Reverse Merger With Tocagen Takes Forte’s Dermatology Ambitions Public

Feb 20 2020

HLB Takes First Expansion Step Via Immunomic Acquisition

Feb 20 2020

Novartis Logs Into India With Digital Innovation Hub

Feb 20 2020

RedHill Biopharma Gets Rights To Naloxegol, No Longer Core At AstraZeneca

Feb 25 2020

Genix Acquires 30 Ophthalmic Dossiers In Canada

Feb 14 2020

Stada Grabs GSK Brands In EU

Feb 25 2020

Beximco And Mylan Strike Biosimilars Deal

Feb 24 2020

No More Big Fish In A Small Pond: Yuhan Opts For Globalization For Long-Term Growth

May 22 2019

Almirall’s Dermatology Pitch Takes Shape

Aug 04 2019

Related Companies

AstraZeneca PLC

RedHill Biopharma Ltd.

HealthCare Royalty Partners

STADA Arzneimittel AG

Viatris Inc.

Biocon, Ltd.

Immatics N.V.

Bristol Myers Squibb Company

Genmab A/S

Amgen, Inc.

Tocagen, Inc.

Immunomic Therapeutics, Inc.

Novartis AG

Codagenix Inc.

Serum Institute of India Pvt. Ltd.

Paratek Pharmaceuticals, Inc.

Almirall SA

Allergan plc

Bicycle Therapeutics, plc

Genentech, Inc.

Roche Holding AG

Nimble Therapeutics, Inc

Five Prime Therapeutics, Inc.

Seagen Inc.

Bristol Myers Squibb Company

Genetix Biotherapeutics

ADC Therapeutics SA

GSK plc

UCB S.A.

Takeda Pharmaceutical Co. Ltd.

Astellas Pharma, Inc.

Merck & Co., Inc.

Fresenius SE & Co. KGaA

CSL Vifor

Yuhan Corporation

Additional Topics

Deals Business Strategies M & A Commercial Coronavirus COVID-19 BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window